Total Payments
$60,552
2024 Payments
$2,165
Companies
46
Transactions
593
Medicare Patients
30,880
Medicare Billing
$2.0M
Payment Breakdown by Category
Other$46,486 (76.8%)
Food & Beverage$10,724 (17.7%)
Travel$2,236 (3.7%)
Consulting$1,100 (1.8%)
Education$6.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,486 | 20 | 76.8% |
| Food and Beverage | $10,724 | 559 | 17.7% |
| Travel and Lodging | $2,236 | 10 | 3.7% |
| Consulting Fee | $1,100 | 3 | 1.8% |
| Education | $6.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $16,487 | 28 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $15,249 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $10,222 | 78 | $0 (2024) |
| Daiichi Sankyo Inc. | $8,920 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $2,611 | 75 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,178 | 77 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $531.37 | 31 | $0 (2024) |
| PFIZER INC. | $485.70 | 29 | $0 (2024) |
| Amgen Inc. | $455.94 | 28 | $0 (2024) |
| Boston Scientific Corporation | $442.76 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,165 | 85 | Vital Connect, Inc ($239.85) |
| 2023 | $1,838 | 72 | AstraZeneca Pharmaceuticals LP ($530.69) |
| 2022 | $3,644 | 62 | AstraZeneca Pharmaceuticals LP ($2,667) |
| 2021 | $7,326 | 60 | AstraZeneca Pharmaceuticals LP ($6,480) |
| 2020 | $2,404 | 47 | Janssen Pharmaceuticals, Inc ($1,722) |
| 2019 | $1,253 | 70 | Janssen Pharmaceuticals, Inc ($225.29) |
| 2018 | $11,020 | 96 | SANOFI-AVENTIS U.S. LLC ($6,112) |
| 2017 | $30,901 | 101 | E.R. Squibb & Sons, L.L.C. ($11,021) |
All Payment Transactions
593 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Obesity | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/02/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $146.49 | General |
| Category: AVVIGO_IC | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $65.30 | General |
| Category: CARDIOLOGY | ||||||
| 11/15/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Vascular | ||||||
| 11/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $107.20 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $18.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2024 | Vital Connect, Inc | VITALPATCH RTM (Device) | Food and Beverage | In-kind items and services | $41.50 | General |
| Category: CARDIOLOGY | ||||||
| 10/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 7,880 | 11,181 | $3.0M | $474,567 |
| 2022 | 30 | 8,636 | 12,368 | $3.0M | $490,460 |
| 2021 | 30 | 7,583 | 10,367 | $3.0M | $504,259 |
| 2020 | 31 | 6,781 | 9,129 | $2.8M | $532,339 |
Total Patients
30,880
Total Services
43,045
Medicare Billing
$2.0M
Procedure Codes
141
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 727 | 1,130 | $197,750 | $99,420 | 50.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 1,030 | 1,071 | $962,730 | $52,998 | 5.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 356 | 363 | $435,810 | $46,407 | 10.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 136 | 136 | $273,573 | $38,276 | 14.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 245 | 614 | $87,802 | $36,706 | 41.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 3,121 | 4,609 | $175,142 | $25,934 | 14.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 45 | 63 | $184,590 | $25,914 | 14.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 127 | 251 | $69,527 | $22,881 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 158 | 158 | $48,054 | $18,150 | 37.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 100 | 400 | $45,600 | $17,809 | 39.1% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 101 | 102 | $117,708 | $15,748 | 13.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 831 | 1,294 | $120,342 | $13,209 | 11.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 123 | $24,969 | $11,202 | 44.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 54 | 55 | $21,120 | $7,169 | 33.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 66 | 66 | $20,592 | $6,514 | 31.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 135 | 135 | $49,545 | $6,169 | 12.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 31 | 31 | $46,965 | $6,132 | 13.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 52 | 52 | $17,524 | $4,218 | 24.1% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 49 | 55 | $13,207 | $3,858 | 29.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 74 | 74 | $31,450 | $3,741 | 11.9% |
| 93307 | Ultrasound of heart | Office | 2023 | 23 | 25 | $16,025 | $2,252 | 14.1% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 13 | $10,842 | $2,165 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,925 | $1,763 | 60.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 21 | 21 | $3,024 | $1,232 | 40.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 15 | 15 | $7,485 | $1,225 | 16.4% |
About Dr. Anil Om, M.D
Dr. Anil Om, M.D is a Cardiovascular Disease healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972560332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anil Om, M.D has received a total of $60,552 in payments from pharmaceutical and medical device companies, with $2,165 received in 2024. These payments were reported across 593 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($46,486).
As a Medicare-enrolled provider, Om has provided services to 30,880 Medicare beneficiaries, totaling 43,045 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Florence, SC
- Active Since 04/28/2006
- Last Updated 04/15/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1972560332
Products in Payments
- PRALUENT (Drug) $16,353
- ELIQUIS (Drug) $15,372
- FARXIGA (Drug) $9,670
- Savaysa (Drug) $8,883
- XARELTO (Drug) $2,506
- ENTRESTO (Drug) $886.17
- LifeVest (Device) $531.37
- BRILINTA (Drug) $445.59
- Repatha (Biological) $380.69
- LEQVIO (Drug) $291.94
- VERQUVO (Drug) $281.85
- KENGREAL (Drug) $243.09
- VITALPATCH RTM (Device) $239.85
- NEXLETOL (Drug) $228.18
- JARDIANCE (Drug) $184.48
- FLOWTRIEVER CATHETER, S (Device) $174.22
- ONYX FRONTIER (Device) $168.95
- CAMZYOS (Drug) $146.75
- AVVIGO Guidance System (Device) $146.49
- Vascepa (Drug) $140.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Florence
Dr. Jeffrey Reichard, M.d, M.D
Cardiovascular Disease — Payments: $83,451
Cardiovascular Disease $83,451
Dr. Therese Lango, Md, MD
Cardiovascular Disease — Payments: $37,405
Cardiovascular Disease $37,405
Dr. Anand Mishra, M.d, M.D
Cardiovascular Disease — Payments: $34,384
Cardiovascular Disease $34,384
Dr. Brian Blaker, Md, MD
Cardiovascular Disease — Payments: $23,276
Cardiovascular Disease $23,276
Gavin Leask, M.d, M.D
Cardiovascular Disease — Payments: $18,799
Cardiovascular Disease $18,799
Prabal Guha, M.d, M.D
Cardiovascular Disease — Payments: $15,809
Cardiovascular Disease $15,809